Literature DB >> 33285364

Assessment of bisphosphonate treated-osteoblast behaviors by conventional assays and a simple digital image analysis.

Somying Patntirapong1, Chatvadee Chanruangvanit2, Kwankamol Lavanrattanakul2, Yodhathai Satravaha2.   

Abstract

The main objective of this study was to analyze the changes in osteoblast behaviors by two different methods, a simple digital image analysis method and conventional assays. Osteoblast progenitor cells and osteoblasts were treated with alendronate (ALN; a nitrogen-containing bisphosphonate). Osteoblast behaviors such as the uptake of ALN, cell proliferation, cell differentiation, and mineralized nodule formation were examined. Quantitative assessments were conducted using a publically available ImageJ software along with conventional methods. Furthermore, ImageJ method and conventional assay for mineralized nodule formation were performed simultaneously and were compared in order to demonstrate the reliability of ImageJ analysis. Osteoblast precursors and osteoblasts responded to ALN treatments. The software could identify various colors and allowed for the quantification of staining intensity and area coverage. Both image analysis and conventional assays detected the changes in cell behaviors between treated and untreated samples. For alizarin red S assay, the staining intensity calculated by ImageJ analysis was comparable to the absorbance measured by conventional assay. These findings showed that digital image analysis along with conventional assays could be used for quantitative assessment to evaluate osteoblast alteration by drug treatment. Image analysis method is practical and might be useful for other applications in the field of biology and medical sciences. It could also be employed in a combination with the conventional assays to strengthen the data.
Copyright © 2020 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Alizarin red S; Alkaline phosphatase; Bisphosphonate; Cell confluence; Digital image analysis; Fluorescence staining

Year:  2020        PMID: 33285364     DOI: 10.1016/j.acthis.2020.151659

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  4 in total

1.  Duration and timing of bisphosphonate treatment as factors determining osteoblast mineralization.

Authors:  Somying Patntirapong
Journal:  J Oral Biol Craniofac Res       Date:  2022-07-31

2.  Non-viral CRISPR activation system targeting VEGF-A and TGF-β1 for enhanced osteogenesis of pre-osteoblasts implanted with dual-crosslinked hydrogel.

Authors:  Guo Chen; Shaohui Deng; Mingxiang Zuo; Jin Wang; Du Cheng; Bin Chen
Journal:  Mater Today Bio       Date:  2022-07-11

3.  Enhanced anti-cancer effects of oestrogen and progesterone co-therapy against colorectal cancer in males.

Authors:  Amani A Mahbub; Akhmed Aslam; Mohamed E Elzubier; Mohamed El-Boshy; Abdelghany H Abdelghany; Jawwad Ahmad; Shakir Idris; Riyad Almaimani; Aiman Alsaegh; Mahmoud Zaki El-Readi; Mohammed A Baghdadi; Bassem Refaat
Journal:  Front Endocrinol (Lausanne)       Date:  2022-10-03       Impact factor: 6.055

4.  In Vivo and In Vitro Enhanced Tumoricidal Effects of Metformin, Active Vitamin D3, and 5-Fluorouracil Triple Therapy against Colon Cancer by Modulating the PI3K/Akt/PTEN/mTOR Network.

Authors:  Riyad Adnan Almaimani; Akhmed Aslam; Jawwad Ahmad; Mahmoud Zaki El-Readi; Mohamed E El-Boshy; Abdelghany H Abdelghany; Shakir Idris; Mai Alhadrami; Mohammad Althubiti; Hussain A Almasmoum; Mazen M Ghaith; Mohamed E Elzubeir; Safaa Yehia Eid; Bassem Refaat
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.